Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

Philipp Harter; Patricia Pautier; Els Van Nieuwenhuysen; Alexander Reuss; Andres Redondo; Kristina Lindemann; Christian Kurzeder; Edgar Petru; Florian Heitz; Jalid Sehouli; Nikolaus Degregorio; Pauline Wimberger; Alexander Burges; Nadin Cron; Jonathan Ledermann; Domenica Lorusso; Xavier Paoletti; Frederik Marme

doi:10.1136/ijgc-2020-001572

Article metrics

other Versions

You are currently viewing an earlier version of this article (June 30, 2020).
View the most recent version of this article

Clinical trial

Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

Online download statistics by month:

Online download statistics by month: June 2020 to March 2023

	Abstract	Full	Pdf
Jun 2020	58	2	2
Jul 2020	795	57	39
Aug 2020	216	13	13
Sep 2020	107	8	1
Oct 2020	170	7	6
Nov 2020	150	6	5
Dec 2020	515	21	7
Jan 2021	241	8	4
Feb 2021	158	6	4
Mar 2021	186	2	5
Apr 2021	135	6	5
May 2021	68	6	6
Jun 2021	7	4	1
Jul 2021	4	1	1
Aug 2021	9	3	4
Sep 2021	5	3	2
Oct 2021	127	11	8
Nov 2021	127	3	1
Dec 2021	179	6	4
Jan 2022	136	11	3
Feb 2022	76	4	2
Mar 2022	197	1	1
Apr 2022	150	4	2
May 2022	150	2	1
Jun 2022	127	3	1
Jul 2022	158	5	1
Aug 2022	136	12	7
Sep 2022	154	5	1
Oct 2022	198	5	2
Nov 2022	211	3	1
Dec 2022	78	2	1
Jan 2023	75	0	0
Feb 2023	118	3	1
Mar 2023	95	3	1
Total	5316	236	143

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Online download statistics by month:

Online download statistics by month: June 2020 to March 2023

Read the full text or download the PDF:

Log in using your username and password